#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Transferrin decreased Mycobacterium abscessus infection Medulloblastoma Neurotrophic keratopathy Congenital pseudarthrosis Myeloproliferative neoplasm Marginal zone lymphoma recurrent Peritoneal mesothelioma malignant Kaposi's sarcoma Head and neck cancer Bulbospinal muscular atrophy congenital Microscopic polyangiitis Amyotrophic lateral sclerosis Congenital absence of bile ducts Chondrosarcoma More trials…

    Learn about Rare Diseases

    Advanced systemic mastocytosis – Treatment Pleural mesothelioma malignant – Life with Disease Rosai-Dorfman syndrome – Trials in Disease Netherton’s syndrome – Diagnostics Hereditary angioedema – Life with Disease Testicular leiomyosarcoma – Diagnostics Friedreich’s ataxia Arterial tortuosity syndrome – Trials in Disease Breast angiosarcoma – Trials in Disease Angiosarcoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Methylprednisolone Aceponate Encaleret Sulfate SC0062 Dexamethasone Ph. Eur. Tildacerfont Benzyl Alcohol Festuca Rubra Pollen Isis 678354 Sodium Salt Promazine Hydrochloride Ecoo6A Teverelix Xp-Dc+Tl+Klh Bnt314 Dotatate Octreotide Hydrochloride Vindesine Sulfate Regorafenib Edg-5506 Ltp001 Berotralstat More therapies…

    Learn about Your Condition

    Erectile dysfunction Strongyloidiasis Acute HIV infection Herpes simplex meningitis Gaucher's disease type I Essential hypertension Leukaemia Autoimmune hepatitis Reperfusion injury Neck pain Becker's muscular dystrophy Angiosarcoma non-metastatic Peritoneal sarcoma Primary hyperthyroidism Laparoscopic surgery More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Universitaire Rouen

Centre Hospitalier Universitaire Rouen

1 Rue De Germont, Rouen, 76000, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Tolerance of Intra-Articular Injection of Autologous Stromal Vascular Fraction for Adults with Thumb Arthritis (Rhizarthrosis)

    Recruiting

    2 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Autologous Adipose Tissue-Derived Stromal Vascular Fraction
    France

  • Study on Medulloblastoma Treatment in Children Aged 3-5 Using Carboplatin and Drug Combination

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Vinblastine Sulfate
    • Carboplatin
    • Cisplatin
    Austria Belgium Czechia Finland France Germany +4

  • Study of CAPOX or FOLFOX chemotherapy before surgery in patients with obstructive colon cancer treated with colostomy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colon cancer
    Investigated Drugs:
    • Levoleucovorin
    • Capecitabine
    • Fluorouracil
    France

  • Study on Bortezomib and Drug Combination for Children with High-Risk Relapsed Acute Lymphoblastic Leukemia (ALL)

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Bortezomib
    • Dexamethasone
    • Methotrexate
    Austria Belgium Czechia Finland France Germany +5

  • Study on the Effects of Belatacept, Ciclosporin, and Tacrolimus on Blood Vessel Health in Kidney Transplant Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Belatacept
    • Ciclosporin
    • Glyceryl Trinitrate
    France

  • Study of rituximab and mycophenolate mofetil combination therapy compared to placebo for patients with interstitial lung disease related to systemic sclerosis

    Recruiting

    4 1 1
    Investigated Diseases:
    • Systemic sclerosis pulmonary
    Investigated Drugs:
    • Mycophenolate Mofetil
    • Rituximab
    France

  • Study of Volrustomig and Drug Combination for Patients with Early-stage Resectable Non-small Cell Lung Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage II
    • Non-small cell lung cancer stage III
    • Non-small cell lung cancer stage IIIA
    Investigated Drugs:
    • Falbikitug
    • Monalizumab
    • Oleclumab
    Belgium France Hungary Ireland Italy Portugal +1

  • Study on the Effectiveness of INM004 for Children with Hemolytic Uremic Syndrome Caused by Shiga Toxin-Producing E. coli

    Recruiting

    3 1
    Investigated Drugs:
    • Equine Immunoglobulin F(Ab’)2 Fragments Targeting Shiga Toxin
    Belgium France Germany Ireland Italy The Netherlands +2

  • Study Comparing Clarithromycin and Azithromycin for Treating Mycobacterium Avium Complex Lung Infections in Adults

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Mycobacterium avium complex infection
    Investigated Drugs:
    • Azithromycin
    • Clarithromycin
    • Ethambutol Hydrochloride
    France

  • Study on the Effects of Caffeine on Cognitive Function in Patients with Early to Moderate Alzheimer’s Disease

    Recruiting

    3 1
    Investigated Drugs:
    • Caffeine
    France
Previous Page
1 … 10 11 12 13 14 … 48
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!